Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript Summary
Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript Summary
Encompass Health has expanded its capacity by adding 99 beds in Q3, including two new de novo hospitals with a total of 89 beds and an expansion of 10 beds in existing facilities.The following is a summary of the Encompass Health Corporation (EHC) Q3 2024 Earnings Call Transcript:
以下是encompass health公司（EHC）2024年第三季度业绩会议呼叫成绩单摘要：
Financial Performance:
金融业绩：
Encompass Health reported a revenue increase of 11.9% reaching $1.35 billion, and an adjusted EBITDA increase of 13.4% to $269.3 million in Q3 2024.
Discharges increased by 8.8%, with total revenue per discharge growth of 2.5%.
Encompass Health报告营业收入增长11.9%，达到13.5亿美元，并调整后的EBITDA增长13.4%，达到26930万美元，截止到2024年第三季度。
出院人数增长8.8%，每位出院患者的总收入增长2.5%。
Business Progress:
业务进展：
Encompass Health has expanded its capacity by adding 99 beds in Q3, including two new de novo hospitals with a total of 89 beds and an expansion of 10 beds in existing facilities.
They anticipate opening one more de novo, a 61-bed hospital in Houston in 2024, and adding approximately 22 more beds to existing hospitals, marking a move towards full prefabrication in construction to reduce costs and expedite completion.
Encompass Health在第三季度通过增加99张床位扩大了其能力，其中包括两家新的全新医院，共计89张床位，以及现有设施的10张床位扩建。
他们预计在2024年在休斯敦开设一家61张床位的全新医院，并在现有医院新增约22张床位，标志着向完全预制化施工以降低成本并加快完工速度迈出了一步。
Opportunities:
机会：
The aging US population and the chronic health conditions that accompany aging fuel demand for inpatient rehabilitation services, suggesting a growing market for Encompass Health's services.
随着美国人口老龄化及老年健康问题的增多，需要接受住院康复服务的需求增加，预示着encompass health服务的市场需求日益增长。
Risks:
风险：
Hurricanes Helene and Milton impacted several operational aspects, including hospital evacuations and damage to facilities, although the financial implications appear to be minor with an estimated expense of less than $1 million for Q4.
飓风赫莲和米尔顿影响了多个运营方面，包括医院疏散和设施损坏，尽管在财务影响上似乎较小，预估四季度的开支不到100万美元。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章内容的准确性无法完全保证。有关更全面的详细信息，请参阅IR网站。本文只是为投资者提供参考，没有任何指导或推荐建议。
